|
|||||||||||||||
|
|
Feb
25 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________
Thursday Feb. 25, 2010 Today's CRWE NEWSWIRE Highlights: MPPC and THRR
myPhotopipe.com, Inc. is a web-based online provider of digital photo processing, photo finishing, photo-sharing, and related services. The Company's unique blend of 1000 print options, combined with manual print inspections and professional color management, have positioned myPhotopipe.com as one of the fastest-growing providers of digital photography services for professionals and serious amateurs. Recently, myPhotopipe.com reported preliminary results for the quarter ended December 31, 2009. Revenues increased 8.5% to $512,466 in the fourth quarter of 2009, compared with $472,415 in the three months ended December 31, 2008. December revenues rose to $216,109, versus $181,855 in the prior-year month, for a gain of 18.8%. This represents the fourth consecutive month of record revenues and the sixth consecutive month of year-over-year revenue improvement since the Company overhauled its management team, marketing initiatives, and product mix. myPhotopipe.com is looking to become a leading player in the Multi Billion Dollar photography market. John Budraitis, a former Kodak executive with 23 years of professional photography industry experience, is now myPhotopipe.com’s Director of Sales. With an impressive track record of technological and sales experience, John Budraitis is leading the company’s entry into the billion-dollar-plus event photography market. More about MPPC at www.myphotopipe.com
Thresher Industries, Inc. is a leading manufacturer of low carbon footprint conventional and custom machined die castings made from 100% recycled aluminum and metal matrix composites. Based in Hanford, California, the Company operates an ISO 9000-compliant, "green" foundry that integrates bio-degradable technologies and processes to lower the economic and environmental costs of production. Thresher offers full engineering support, designing, and prototype development to a variety of industries including: agriculture, aerospace, defense, transportation, and automotive in the U.S. and Europe. Recently, Thresher Industries, Inc. has received forecast of purchases for 2010 from an S&P 500 company. Thresher anticipates beginning production for both parts in February. Thresher is estimated to receive between $400,000 and $625,000 in orders for both parts for year 2010 from this S&P 500 company. Thresher has also quoted value added services to these two parts that could raise its revenue another $330,000 to $525,000 for year 2010. Along with these estimates, Thresher anticipates orders for new parts this year that could be as high as $150,000. There is the potential for Thresher to book as much as $1.4m in revenue for year 2010 from this S&P 500 company. Furthermore, Thresher Industries has been supplying lighting components to Cooper Industries, Ltd., its previously referred to S&P 500 Conglomerate. These components are being used in a new product line of energy efficient LED light fixtures. Production orders were placed, and deliveries began in Q4 2009, with anticipated follow up orders to come soon to Thresher's high pressure casting Hanford facility. Cooper Industries, Ltd. is a global manufacturer with 2008 revenues of $6.5 billion, approximately 88 percent of which are from electrical products. More about THRR at www.thresherindustries.com THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: CRWENewswire and Crown Equity Holdings, Inc. employees are not registered as an Investment Advisor or broker/dealers in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Many times we are compensated to feature companies on our site which causes a conflict in interest. Our Newsletter(s) and Alerts are written and published by Crown Equity Holdings, Inc., employees and/or contractors employed by the company. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. CRWENewswire and Crown Equity Holdings, Inc., encourages readers and investors to supplement the information in these reports with independent research and other professional advice. . All information on featured companies is provided by the companies profiled, or is available from public sources and CRWENewswire and Crown Equity Holdings, Inc. makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Once again; neither Crown Equity Holdings, Inc., nor any of its affiliates are not registered investment advisers or a broker dealers. CRWENewswire has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor’s sole risk.Never invest in any stock featured on our sites or emails unless you can afford to lose your entire investment. Full disclaimer can be read at www.CRWENewswire.com.
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
.png)
.png)
.png)
|
Feb
25 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 25, 2010
Upgrades
Downgrades
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
19 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 19, 2010
 Majic Wheels Corporation (OTC BB: MJWL) As terrorism continues it spread across the world this type of technology is
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty-five thousand dollars compensation from Majic Wheels Corp. (MJWL.OB) for 4 days of media advertisement services. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
17 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 17, 2010 NEW YORK, NY--(CRWENEWSWIRE) - United EcoEnergy Corp.'s (OTC.BB:UEEC - News) principal operating subsidiary, Epic Wound Care, Inc., today announced that it has successfully accomplished its manufacturer's registration. United EcoEnergy develops, manufactures and markets products and technologies in the healthcare sector. The registration describes the product as "Gauze/Sponge Nonresorbable for External Use" and is grouped as a Device Class 1 which is exempt from premarket submission. The product will be marketed under the registered brand names ActCel Gauze?, ActJel Gauze? and ABC Gauze? and Hemostyp?. These brand names are owned by Epic or its distributor Coreva Health Care Sciences. Craig Bluth, President of Coreva, stated that, "The completed registration allows the product to be marketed which will be in packaging configurations to address specific market segments underspecific brand identification and labels for each market. We now can fulfill our present orders while continuing to build our product line and commence shipping of our product worldwide." It is a very exciting and important time for us and the product, said Mr. Bluth. We have recently attended numerous events catered to the US military and retail markets. The product was extremely well received and we can now address those markets. About Epic Wound Care. Inc. (www.abcgauze.com) Epic has developed a ground-breaking gauze product designed for the wound care market. The gauze can be used on any wound where bleeding is present. Upon contact with moisture, the gauze forms a gel-like substance that acts as a homeostatic agent to address bleeding quickly. Once bleeding has ceased and coagulation has occurred, the product can be rinsed away with saline solution or lukewarm water. About United EcoEnergy United EcoEnergy Corp (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's principal operating subsidiary is Epic Wound Care, Inc. which produces a hemostatic gauze, a collagen-like natural substance created from chemically treated cellulose, that is designed to address severe bleeding in wound care applications. The Company is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition. Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
11 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 11, 2010
As a part of the first phase, Pepper Rock will re-enter 2 existing natural gas wells which had previously been in production and are currently shut-in. The operator will perform C02 fracture stimulation ("frac") on both wells utilizing 100,000 pounds of sand in anticipation of resuming production. In addition, the Company plans to test other potential producing formations in the 4600 to 4800 foot level of the wells. The Company anticipates that re-entry efforts will commence within the next 2 weeks and plans to subsequently test the wells for commercial production as soon as possible thereafter. Forward-Looking Statements
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Disclaimer:Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
11 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 11, 2010 CHICAGO, IL--(CRWENEWSWIRE) - Pepper Rock Resources Corp. an emerging energy company focusing on the potential for major exploration and production reclamation projects in the oil and gas sector, today reported that the company has made an initial investment of $300,000 as part of phase one of three phases in its joint venture agreement with Oxalis Energy Group, Inc., based in Katy, Texas. "This payment represents the first part of our agreement with Oxalis to re-work 2 initial natural gas wells on a property in West Texas and bring the gas production online," said Pepper Rock Resources President Phil Kueber. "As part of our corporate strategy to acquire proven non-producing reserves and develop them, we believe this is a good step towards achieving our goals." The second phase of the joint venture will have the Company drill a minimum of 10 natural gas wells with an option to drill another 10. Each well will cost approximately $500,000 to drill and complete. After payout, Pepper Rock and Oxalis will each retain a 50% working interest in the producing wells. Recent geological reports estimate proven undeveloped reserves of 100 billion cubic feet of natural gas. Another recent reserve report suggests a potential valuation of $285 million to $423 million, using a base price of $3.50 per thousand cubic feet of natural gas. Mr. Kueber further stated, "As an added incentive, this agreement offers a provision that includes the opportunity to acquire future rights to develop additional oil and gas prospects and projects with Oxalis Energy Group." Pepper Rock is currently completing geological and geophysical evaluation on these prospects to determine their cost and viability. Forward-Looking Statements This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the Company to be different from those expressed or implied. Certain statements in this release, and other written or oral statements made by the Company, including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "outlook," "target," "objective," "plan," "goal," "pursue," "on track," and similar expressions, are "forward-looking statements" and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied. The Company assumes no obligation and does not intend to update these forward-looking statements.
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Disclaimer:Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
11 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ HOUSTON, TX, Feb 11 /CRWENEWSWIRE/ Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM - News) announced today that it has signed a definitive agreement to acquire all of the stock of StemTroniX Inc., a Texas corporation (“StemTroniX”). Power3 plans to effectuate the acquisition of StemTroniX by merging a wholly-owned subsidiary of the Company with and into StemTroniX. StemTroniX will remain as the surviving company in the merger and will become a wholly-owned subsidiary of Power3. The acquisition of StemTroniX is expected to be completed in April 2010. Crown Equity Holdings, Inc.
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Disclaimer:Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
11 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 11, 2010 Pepper Rock Resources Corp., an exploration stage corporation, intends to explore for gold. It plans to explore the Pepper Rock Mining Claim comprising 20 acres located in Clark County, Nevada. PEPR an emerging company focusing on low risk exploration and production reclamation projects in the oil and gas sector, reports today that it is pleased with its joint venture agreement with Oxalis Energy Group, Inc. and is optimistic to further the West Texas Project. PEPR intends to re-enter two existing wells and drill as many as ten new natural gas wells. The drilling program in this significant project encompasses 21,000 acres of high quality natural gas at depths of 4,400 to 5,200 feet.
________________________________________
Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Disclaimer:Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
03 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 3, 2010 Power3 Plans to Present NuroPro for the Second Year in a Row to the International Congress of Alzheimer's Disease HOUSTON, Feb. 3, 2010 (CRWENEWSWIRE) -- Power3 Medical Products, Inc. (OTCBB:PWRM - News) announced that 4 abstracts covering results from clinical validation trials of the NuroPro® AD test for Alzheimer's disease were submitted to the 2010 annual meeting of the International Congress of Alzheimer’s Disease, taking place July 2010. The NuroPro AD test was developed to help clinicians distinguish patients with Alzheimer’s disease from "normal" individuals and patients with other neurological disorders. The test, developed by Power3, is a panel of 57 blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability a patient has Alzheimer’s disease. The test is intended to solve the critical challenge facing physicians, clinicians, and patients for quick, early stage, and accurate diagnosis of this debilitating disease as well as to provide guidance for therapy, and monitor treatment response. The four studies present the capabilities of NuroPro for accurate diagnosis, targeted therapy and drug response monitoring. They involve a total of 154 Alzheimer’s disease and 91 Parkinson’s disease patients, 210 age-matched normal and 173 disease control individuals. The abstracts report the combined results from the clinical validation trials of the NuroPro® AD and NuroPro PD tests, conducted by the Power3 scientific team, led by medical director Lourdes R. Bosquez, MD and chief scientific officer, Ira L. Goldknopf, Ph.D., in collaboration with Marwan Sabbagh, MD, director of the Banner Sun Health Research Institute, Sun City, Arizona, Katerina Markopoulou, M.D., Assistant Professor of Neurology at the University of Thessaly, Larissa Greece, along with previous studies Power3 conducted with Stanley H. Appel, MD during his tenure as Chairman of Neurology, Baylor College of Medicine, Houston TX. Dr. Appel is now Co-Director of the Methodist Neurological Research Institute, Houston, TX, and continues to be chairman of the scientific advisory board of Power3. “To date we have not been successful in treating dementia because of the complexity of the diagnosis,” said Dr. Bosquez, Power3’s medical director. “These studies show how the NuroPro AD test can specifically diagnose Alzheimer’s disease and also address patient to patient differences. One size does not fit all.” “Treatment of Alzheimer’s disease has a greater chance of success if it is detected in its earliest stages. As a neurologist and a clinician I am excited at the potential of having this diagnostic tool to detect Alzheimer’s disease and ultimately producing better outcomes and quality of life for those who suffer from the disease,” says Marwan Sabbagh M.D., director of clinical research at Banner Sun Health Research Institute. About Power3 Medical Products, Inc. Power3 Medical Products, http://www.Power3Medical.com, is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas and continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer's, and Parkinson's diseases, breast cancer, and drug resistance. For more information, visit http://www.Power3Medical.com Forward-Looking Statement: This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements and/or Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements. Contact: Crown Equity Holdings, Inc.
________________________________________ Contact Stock-PR Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Disclaimer:Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
|
Feb
03 |
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________ Feburary 3, 2010
Upgrades
Downgrades
________________________________________ Contact Stock-PR Be Sure To Visit stock-pr.ning.com
******Advertisement******
******************************** Disclaimer:Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
|
 |
female, 71 y/o United States 
|
- CRWE NEWSWIRE Highlights: MPPC and THRR (Brought to you by Stock-PR.com)
- Upgrades and Downgrades Stock-PR Reports 2/25/10
- Stock-Pr Mega Stock Watch on MJWL.OB
- Stock-PR Stock Alert on UEEC 2/17/2010
- Pepper Rock Resources Prepares for West Texas Gas Well Re-Entry Program - Stock-PR
- Pepper Rock Resources Announces Investment in Texas Gas Project- Stock-PR
- Stock-PR Stock Alert Power3 Medical Announces Execution of Definitive Agreement to Acquire StemTroniX
- Stock-PR Stock Watch Alert on PEPR on 2/11/2010
- Power3 Medical Submits Four Abstracts of Results of Clinical Validation Trials for NuroPro(R) Blood Test for Alzheimer's Disease
- Stock-PR Upgrades and Downgrades 2/3/10
-
AlbertAimers blogged:
Obama Speech
|
